Generic Drug Price-Fixing
The Joseph Saveri Law Firm is investigating reports that numerous generic drug manufacturers have been fixing the prices of dozens of generic drugs. In the past, U.S. consumers could rely on generic manufacturers to offer critical savings on prescription drug medications. That role has changed in the past 3 to 4 years as the prices of many generic drugs have been rising at alarming rates. These sudden and dramatic price increases appear to be the result of collusion among generic drug manufacturers. In 2016, a generic drug manufacturer reportedly sought leniency from the U.S. government for its role in a generic drug price-fixing conspiracy. More recently, two former pharmaceutical executives pleaded guilty to criminal charges of price-fixing. The U.S. Attorney General as well as twenty State AGs have filed lawsuits alleging price-fixing among generic drug manufacturers, and have made clear that this conduct has been rampant and widespread in the industry.
The Joseph Saveri Law Firm has conducted its own investigation into price-fixing claims involving several generic drugs, and has confirmed that there are strong antitrust claims to be brought for many of these generic pharmaceuticals. Please contact the Joseph Saveri Law Firm if you have purchased (or reimbursed for) generic drugs and you believe the pricing of these purchases and sales may have been impacted by illegal price-fixing.
On May 19, 2017, United States District Judge Cynthia M. Rufe for the Eastern District of Pennsylvania issued an Order appointing the attorneys and law firms to the Plaintiffs’ Steering Committees. The Joseph Saveri Law Firm is among the appointed firms representing members of the End-Payor Plaintiffs PSC.